Cargando…
Engineered reversal of drug resistance in cancer cells—metastases suppressor factors as change agents
Building molecular correlates of drug resistance in cancer and exploiting them for therapeutic intervention remains a pressing clinical need. To identify factors that impact drug resistance herein we built a model that couples inherent cell-based response toward drugs with transcriptomes of resistan...
Autores principales: | Yadav, Vinod Kumar, Kumar, Akinchan, Mann, Anita, Aggarwal, Suruchi, Kumar, Maneesh, Roy, Sumitabho Deb, Pore, Subrata Kumar, Banerjee, Rajkumar, Mahesh Kumar, Jerald, Thakur, Ram Krishna, Chowdhury, Shantanu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902936/ https://www.ncbi.nlm.nih.gov/pubmed/24157835 http://dx.doi.org/10.1093/nar/gkt946 |
Ejemplares similares
-
Functional genomics of lung cancer progression reveals mechanism of metastasis suppressor function
por: Thakur, Ram Krishna, et al.
Publicado: (2014) -
Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression
por: Thakur, Ram Krishna, et al.
Publicado: (2009) -
Metastases suppressor NME2 associates with telomere ends and telomerase and reduces telomerase activity within cells
por: Kar, Anirban, et al.
Publicado: (2012) -
Evidence of genome-wide G4 DNA-mediated gene expression in human cancer cells
por: Verma, Anjali, et al.
Publicado: (2009) -
Non-metastatic 2 (NME2)-mediated suppression of lung cancer metastasis involves transcriptional regulation of key cell adhesion factor vinculin
por: Thakur, Ram Krishna, et al.
Publicado: (2014)